Table 4.
Group | n | MDA (nmol/mg) | SOD (U/mg) |
---|---|---|---|
Sham | 6 | 1.17±0.26 | 100.53±6.47 |
CME | 6 | 3.21±0.36* | 62.71±5.31* |
low | 6 | 2.36±0.43*#a | 78.90±2.38*#a |
High | 6 | 1.75±0.10*# | 85.12±2.70*# |
Notes: Alprostadil injection improved myocardial antioxidant ability following CME. The results are presented as the mean±standard deviation (SD) of at least three independent experiments. *P<0.05, compared with Sham group; #P<0.05, compared with CME group; aP<0.05, compared with High group.
Abbreviations: CME, coronary microembolization; Low, CME plus alprostadil injection (2 μg/kg); High, CME plus alprostadil injection (4 μg/kg); MDA, malondialdehyde; SOD, superoxide dismutase.